Market Overview

Sage Therapeutics (NASDAQ: SAGE)

75.57 -7.13 (-8.62%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/16/20B of A SecuritiesMaintainsBuy95.0
11/16/20Morgan StanleyDowngradesEqual-Weight85.0
11/06/20Canaccord GenuityMaintainsBuy135.0
11/06/20BMO CapitalMaintainsOutperform89.0
11/06/20HC Wainwright & Co.MaintainsNeutral81.0
9/11/20WedbushUpgradesOutperform65.0
8/24/20Morgan StanleyMaintainsOverweight87.0
8/06/20Raymond JamesUpgradesOutperform70.0
5/26/20RBC CapitalReiteratesOutperform75.0
5/08/20WedbushDowngradesNeutral37.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter